Investment
Features
FeesSafety
Academy
More
Pluang+

Compare eBay Inc (EBAY) vs Cassava Sciences Inc (FLNA) Price & Performance

Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

eBay Inc vs Cassava Sciences Inc — how do they compare? eBay Inc trades at $106.26 (market cap $47.93B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: eBay Inc is far larger — about 1003.8× Cassava Sciences Inc's market cap, and eBay Inc pays a 1.15% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

EBAYFLNA
Market Cap
$47.93B$47.75M
Volume
5,186,418
Sector
Consumer CyclicalHealth
52-Week High
$118.96$4.64
52-Week Low
$79.41$0.87
Enterprise Value
$51.75B-$34.93M
Dividend Yield
1.15%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

eBay Inc

EBAY trades at $111.98, up 1.67% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals, including a net income margin of 18.57% and ROE of 47.38%, supported by revenue growth to $11.10B in 2025. Recent news highlights potential partnership talks with GameStop after a withdrawn $56B bid, adding volatility but strategic interest.

Outlook is positive with a consensus price target of $119.85, indicating ~7% upside, driven by earnings momentum and focus category growth. Risks include competitive pressures in e-commerce and market sensitivity to merger speculation. Investors may find value in sustained profitability and analyst buy ratings, though monitor execution on guidance.

Cassava Sciences Inc

FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.

Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About eBay Inc

eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.

Read more on EBAY

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA